Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

astrazeneca_building_white

AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy

January 26, 2021 Manufacturing and Production AstraZeneca, COVID-19

AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …
News
merckincweb

MSD discontinues development of COVID-19 vaccines

January 26, 2021 Manufacturing and Production MSD, Merck

Merck, known as MSD outside of the US and Canada, has announced that the company is discontinuing development of its …
News
abbvie_0

AbbVie’s psoriatic arthritis and ankylosing spondylitis drug gets EU approval

January 26, 2021 Manufacturing and Production AbbVie

The European Commission (EC) has approved AbbVie’s RINVOQTM (upadacitinib 15 mg), an oral, once-daily selective and reversible JAK inhibitor for …
News
drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
Feature
nicki_grundy

Raremark appoints Nicki Grundy as CFO

January 20, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …
Appointment
img_4190-e1376666350337-web

MHRA grants Promising Innovative Medicine Designation to Sanofi’s RSV drug

January 19, 2021 Manufacturing and Production MHRA, Sanofi

The MHRA has granted a Promising Innovative Medicine (PIM) Designation to Sanofi’s nirsevimab, which is being investigated a passive immunisation …
News

NICE recommends cutting-edge lymphoma treatment for NHS use

January 19, 2021 Manufacturing and Production Cancer, NICE

NHS clinicians in England will be able to consider a cutting-edge cancer treatment for some patients with a form of …
News
covaxin

Bharat Biotech advises certain groups against taking its COVID-19 vaccine

January 19, 2021 Manufacturing and Production Bharat Biotech, COVID-19

India’s vaccine developer Bharat Biotech has advised a number of groups to avoid taking its homegrown COVID-19 vaccine, Covaxin. According …
News

Novartis’ Cosentyx available on NHS in Scotland

January 19, 2021 Manufacturing and Production Novartis

Novartis has announced that Cosentyx (secukinumab) 150mg is available in Scotland on the NHS, licensed for adults with active non-radiographic …
News

ConserV and Lawrence Livermore National Laboratory to collaborate on coronavirus vaccine

January 19, 2021 Manufacturing and Production COVID-19, ConserV Bioscience

ConserV Bioscience, a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and Lawrence …
News
novartis_outside_1

Novartis and BeiGene join forces to develop cancer drug tislelizumab

January 12, 2021 Manufacturing and Production BeiGene, Cancer, Novartis

Novartis has signed a strategic collaboration agreement to in-license tislelizumab from BeiGene Ltd in major markets outside of China, accelerating …
News
sos002

Sosei Heptares and PharmEnable collaborate on neurological drug research

January 12, 2021 Manufacturing and Production PharmEnable, Sosei Heptares

Sosei Group Corporation and PharmEnable, a UK drug discovery company, have joined forces to apply their respective technologies to drive …
News
astrazeneca-sign

AstraZeneca seeks EU approval for COVID-19 vaccine

January 12, 2021 Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …
News

Boehringer Ingelheim and Enara Bio to collaborate on cancer immunotherapies

January 12, 2021 Manufacturing and Production Boehringer Ingelheim, Cancer, Enara Bio

Boehringer Ingelheim and Enara Bio have entered into a strategic collaboration and licensing agreement to research and develop novel targeted …
News

Promising new treatment for drug-resistant prostate cancer

January 12, 2021 Manufacturing and Production Cancer

A new experimental drug could offer a promising treatment strategy for men with advanced, drug-resistant prostate cancer, researchers have said. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026